SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-044768
Filing Date
2013-08-12
Accepted
2013-08-12 16:59:17
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v350595_10q.htm 10-Q 294852
2 EXHIBIT 31.1 v350595_ex31-1.htm EX-31.1 9486
3 EXHIBIT 31.2 v350595_ex31-2.htm EX-31.2 9382
4 EXHIBIT 32.1 v350595_ex32-1.htm EX-32.1 4571
  Complete submission text file 0001144204-13-044768.txt   4998466

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nvlt-20130630.xml EX-101.INS 598027
6 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20130630.xsd EX-101.SCH 33020
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20130630_cal.xml EX-101.CAL 34229
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20130630_def.xml EX-101.DEF 161871
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20130630_lab.xml EX-101.LAB 242959
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20130630_pre.xml EX-101.PRE 195687
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-119366 | Film No.: 131030339
SIC: 2834 Pharmaceutical Preparations